Simultaneously evaluating the effects of one-week fluticasone propionate inhalation therapy on lung ventilation and...

Area of Science:

• Pediatric Pulmonology
• Nuclear Medicine
• Respiratory Medicine

Background:

• Asthma affects lung ventilation and alveolar permeability in children.
• Assessing these parameters non-invasively is crucial for effective treatment monitoring.
• Fluticasone propionate is a common inhaled corticosteroid for asthma management.

Purpose of the Study:

• To evaluate the effects of fluticasone propionate inhalation on lung ventilation and alveolar permeability in pediatric asthma.
• To assess the utility of quantitative Tc-99m DTPA radioaerosol inhalation lung scintigraphy in this context.

Main Methods:

• Fifteen children with asthma underwent Tc-99m DTPA radioaerosol inhalation lung scintigraphy.
• Lung ventilation (distribution percentage, D%) and alveolar permeability (clearance slope) were measured before and after one week of fluticasone propionate therapy.
• Quantitative scintigraphy assessed regional lung deposition and clearance rates.

Main Results:

• One-week fluticasone propionate therapy significantly improved lung ventilation (D%) in the right lung.
• No statistically significant changes were observed in alveolar permeability (slope) in the right lung.
• The study demonstrated improved aerosol distribution in the lungs.

Conclusions:

• Fluticasone propionate inhalation therapy effectively improves lung ventilation in pediatric asthma.
• Tc-99m DTPA radioaerosol scintigraphy is a valuable non-invasive tool for simultaneously assessing ventilation and permeability.
• This imaging technique can aid in managing respiratory disorders involving both airways and alveoli.